Sakshi Batra does a 3 Point Analysis of the earnings fine print and shares an outlook on the company.
Post the big ticket acquisition of Arysta LifeScience last year, UPL has reported a subdued set of Q4 results.
While the operating performance (excluding Arysta remained healthy), the combined numbers remained impacted.Sakshi Batra does a 3 Point Analysis of the earnings fine print and shares an outlook on the company.The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .